EXCEED THE SPACE PROVIDED. Heart failure (HF) is designated as an emerging epidemic. Yet, it is not fully characterized. Most data, derived from hospital discharges, cannot measure incidence, have uncertain validity and cannot capture the full burden of HF because of the shift towards outpatient care. Regarding its etiology, the respective role of hypertension and coronary heart disease (CHD) is controversial. Moreover, the prevalence of obesity and diabetes mellitus is increasing, both conditions linked to HF via several mechanisms such that their contribution to HF could conceivably be increasing but remains to be examined. Finally, while the existence of diastolic HF is recognized, its diagnosis is exclusionary based on symptoms of HF in the absence of LV systolic dysfunction. This approach is unsatisfactory, thus the contribution of DHF to HF remains contentious. These striking gaps in knowledge underscore the necessity of a rigorous investigation of the HF epidemic. Through surveillance of the Olmsted County community, we demonstrated the postponement of CHD towards older ages and the decline over time in the severity of hospitalized MI and the incidence of HF after MI. This implies that, if CHD is the main cause of HF, HF should be postponed towards older ages and its incidence relatively stable. During the same period, preliminary findings on HF surveillance suggest that the incidence of first clinical diagnosis of HF may not be increasing as much as implied by hospital discharges and that adverse trends may be occurring preferentially among younger ages. These data from the same community are challenging to reconcile with the concept of an ongoing major contribution of CHD to an epidemic of HF, thereby underscoring the need to rigorously study the epidemiology of HF, which is the focus of this application. We propose 3 specific aims and a community surveillance approach, integrated with our ongoing work on CHD surveillance to investigate the HF epidemic in Olmsted County by characterizing its magnitude and determinants and studying prospectively the contribution of DHF.
Aim 1 will estimate the secular trends in the incidence and in the outcome of validated HF to test the hypotheses that there has been an increase in the incidence of HF, which differs by age and sex and that the survival of HF improved while hospitalization for HF has increased.
Aim 2 will use a case-control approach to characterize the etiology of HF and its changes over time to test the hypotheses that CHD and hypertension confer an excess risk of HF, the magnitude of which is declining over time, that obesity and diabetes mellitus confer an excess risk of HF the magnitude of which is increasing and that the population attributable risk of CHD and hypertension for HF is declining, while that of obesity and diabetes mellitus is increasing over time.
Aim 3 will prospectively characterize the contribution of DHF to HF using brain natriuretic peptide (BNP) among persons with HF and define the prognostic value of BNP in all cases of HF. Thus, the completion of these aims _villprovide important insights into the epidemiology of HF. PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL072435-03
Application #
6832219
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Sorlie, Paul
Project Start
2003-01-15
Project End
2006-12-31
Budget Start
2005-01-01
Budget End
2005-12-31
Support Year
3
Fiscal Year
2005
Total Cost
$674,827
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Gerber, Yariv; Weston, Susan A; Enriquez-Sarano, Maurice et al. (2016) Mortality Associated With Heart Failure After Myocardial Infarction: A Contemporary Community Perspective. Circ Heart Fail 9:e002460
Hasin, Tal; Gerber, Yariv; Weston, Susan A et al. (2016) Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer. J Am Coll Cardiol 68:265-271
Gerber, Yariv; Weston, Susan A; Enriquez-Sarano, Maurice et al. (2016) Atherosclerotic Burden and Heart Failure After Myocardial Infarction. JAMA Cardiol 1:156-62
Bielinski, Suzette J; Pathak, Jyotishman; Carrell, David S et al. (2015) A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) Network. J Cardiovasc Transl Res 8:475-83
Gerber, Yariv; Weston, Susan A; Redfield, Margaret M et al. (2015) A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med 175:996-1004
Gerber, Yariv; Weston, Susan A; Jiang, Ruoxiang et al. (2015) The changing epidemiology of myocardial infarction in Olmsted County, Minnesota, 1995-2012. Am J Med 128:144-51
Dunlay, Shannon M; Redfield, Margaret M; Jiang, Ruoxiang et al. (2015) Care in the last year of life for community patients with heart failure. Circ Heart Fail 8:489-96
Dunlay, Shannon M; Manemann, Sheila M; Chamberlain, Alanna M et al. (2015) Activities of daily living and outcomes in heart failure. Circ Heart Fail 8:261-7
Mohammed, Selma F; Hussain, Saad; Mirzoyev, Sultan A et al. (2015) Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction. Circulation 131:550-9
Chamberlain, Alanna M; Manemann, Sheila M; Dunlay, Shannon M et al. (2014) Self-rated health predicts healthcare utilization in heart failure. J Am Heart Assoc 3:e000931

Showing the most recent 10 out of 86 publications